Pan-yellow fever virus detection and lineage assignment by real-time RT-PCR and amplicon sequencing.


Journal

Journal of virological methods
ISSN: 1879-0984
Titre abrégé: J Virol Methods
Pays: Netherlands
ID NLM: 8005839

Informations de publication

Date de publication:
06 2023
Historique:
received: 20 09 2022
revised: 03 03 2023
accepted: 21 03 2023
medline: 28 4 2023
pubmed: 28 3 2023
entrez: 27 3 2023
Statut: ppublish

Résumé

Yellow fever disease is a viral zoonosis that may result in a severe hemorrhagic disease. A safe and effective vaccine used in mass immunization campaigns has allowed control and mitigation against explosive outbreaks in endemic areas. Since the 1960's, re-emergent of the yellow fever virus has been observed. The timely implementation of control measures, to avoid or contain an ongoing outbreak requires rapid specific viral detection methods. Here a novel molecular assay, expected to detect all known yellow fever virus strains, is described. The method has demonstrated high sensitivity and specificity in real-time RT-PCR as well as in an endpoint RT-PCR set-up. Sequence alignment and phylogenetic analysis reveal that the amplicon resulting from the novel method covers a genomic region whose mutational profile is completely associated to the yellow fever viral lineages. Therefore, sequencing analysis of this amplicon allows for assignment of the viral lineage.

Identifiants

pubmed: 36972832
pii: S0166-0934(23)00042-3
doi: 10.1016/j.jviromet.2023.114717
pii:
doi:

Substances chimiques

Yellow Fever Vaccine 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

114717

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Giovanni Faggioni (G)

Army Medical Center, Scientific Department, Rome, Italy. Electronic address: giovanni.faggioni@gmail.com.

Riccardo De Santis (R)

Army Medical Center, Scientific Department, Rome, Italy.

Filippo Moramarco (F)

Army Medical Center, Scientific Department, Rome, Italy.

Mario Di Donato (M)

Army Medical Center, Scientific Department, Rome, Italy.

Angelo De Domenico (A)

Army Medical Center, Scientific Department, Rome, Italy.

Filippo Molinari (F)

Army Medical Center, Scientific Department, Rome, Italy.

Giancarlo Petralito (G)

Army Medical Center, Scientific Department, Rome, Italy.

Claudia Fortuna (C)

Department of Infectious, Parasitic and Immunomediated Diseases, Istituto Superiore di Sanità, Rome, Italy.

Giulietta Venturi (G)

Department of Infectious, Parasitic and Immunomediated Diseases, Istituto Superiore di Sanità, Rome, Italy.

Giovanni Rezza (G)

Health Prevention Directorate, Ministry of Health, Rome, Italy.

Florigio Lista (F)

Army Medical Center, Scientific Department, Rome, Italy.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH